Biohaven Pharmaceutical Holding Co Ltd.

Ownership Transactions Reported by 17 Insiders

Industry
Pharmaceutical Preparations
Location
215 Church Street, New Haven, Connecticut

There are no Buy or Sell transactions made by insiders since 7/8/2023

Biohaven Pharmaceutical Holding Co Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vlad Coric Chief Executive Officer, Director $274 M Oct 3, 2022
Declan Doogan Director $222 M Dec 31, 2021
John Tilton Chief Commercial Officer $240 K Oct 3, 2022
George Clark VP, Chief Accounting Officer Oct 3, 2022
Kimberly Gentile SVP, Clinical Operations Oct 3, 2022
Elyse Stock Chief Medical Officer Oct 3, 2022
Matthew Buten Chief Financial Officer Oct 3, 2022
Julia P. Gregory Director Oct 3, 2022
Gregory Bailey Director Oct 3, 2022
Irina Antonijevic Director Oct 3, 2022
Charles Conway Chief Scientific Officer Oct 3, 2022
James Engelhart Strategic Advisor Oct 3, 2022
William Jones CCO-Migraine & Common Disease Oct 3, 2022
John W. Childs Director Oct 3, 2022
Robert J. Hugin Director Oct 3, 2022
Michael Thomas Heffernan Director Oct 3, 2022
Kishan Mehta Director Oct 3, 2022

Recent Insider Transactions by Companies or Individuals for Biohaven Pharmaceutical Holding Co Ltd.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership